BioScrip (NASDAQ: BIOS) has announced the sale of $62.5 million of Series A Convertible Preferred Stock via a private placement to Coliseum Capital Management, LLC and affiliated funds

Mar. 2015

Client: BioScrip is the nation's third largest home infusion provider

Role: Prior to his work at Edgemont, Eugene Goldenberg and his team served as exclusive financial advisor to BioScrip

Location: Elmsford, NY

Sector: Post-Acute, Staffing and Distribution

Lead Banker: Eugene Goldenberg